{
    "clinical_study": {
        "@rank": "21545", 
        "arm_group": {
            "arm_group_label": "Ultherapy\u2122 study treatment", 
            "arm_group_type": "Experimental", 
            "description": "Each subject will receive a customized, high-density, vectored Ulthera System Treatment."
        }, 
        "brief_summary": {
            "textblock": "All enrolled subject will receive one Ultherapy\u2122 treatment.  Study images will be obtained\n      pre-treatment, immediate post-treatment, and at each study follow-up visit.  Enrolled\n      subjects will return for follow-up visits at 90 days, 180 days and 365 days post-treatment."
        }, 
        "brief_title": "Feasibility Study: Higher Density Ulthera\u00ae System Treatment With Vectoring for Treatment of the Face and Neck", 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "condition": "Skin Laxity", 
        "condition_browse": {
            "mesh_term": "Cutis Laxa"
        }, 
        "detailed_description": {
            "textblock": "This is a prospective, single-center clinical trial to evaluate the efficacy of the Ulthera\u00ae\n      System to provide a customized, high-density, vectored Ultherapy\u2122 treatment to lift and\n      tighten the skin of the face and neck. Skin laxity changes from baseline will be assessed at\n      study follow-up visits. Global Aesthetic Improvement Scale scores and patient satisfaction\n      questionnaires will also be obtained."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female, aged 25 to 60 years.\n\n          -  Subject in good health.\n\n          -  Skin laxity in the area(s) to be treated.\n\n          -  Understands and accepts the obligation not to undergo any other procedures in the\n             area(s) to be treated through the follow-up period.\n\n          -  Willingness and ability to comply with protocol requirements, including returning for\n             follow-up visits and abstaining from exclusionary procedures for the duration of the\n             study.\n\n        Exclusion Criteria:\n\n          -  Presence of an active systemic or local skin disease that may affect wound healing.\n\n          -  Severe solar elastosis.\n\n          -  Excessive subcutaneous fat in the area(s) to be treated.\n\n          -  Excessive skin laxity on the area(s) to be treated.\n\n          -  Significant scarring in area(s) to be treated.\n\n          -  Open wounds or lesions in the area(s) to be treated.\n\n          -  Severe or cystic acne on the area(s) to be treated.\n\n          -  Presence of a metal stent or implant in the area(s) to be treated.\n\n          -  Inability to understand the protocol or to give informed consent.\n\n          -  BMI equal to and greater than 30."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "25 Years"
        }, 
        "enrollment": {
            "#text": "21", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 15, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01708512", 
            "org_study_id": "ULT-130"
        }, 
        "intervention": {
            "arm_group_label": "Ultherapy\u2122 study treatment", 
            "description": "Focused ultrasound energy delivered below the surface of the skin", 
            "intervention_name": "Ulthera System Treatment", 
            "intervention_type": "Device", 
            "other_name": "Ultherapy\u2122"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Ulthera\u00ae System", 
            "Ultherapy\u2122 Treatment", 
            "Ulthera, Inc.", 
            "Ultrasound treatment for skin tightening"
        ], 
        "lastchanged_date": "September 9, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Spokane", 
                    "country": "United States", 
                    "state": "Washington", 
                    "zip": "99204"
                }, 
                "name": "Premier Clinical Research"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Feasibility Study: Evaluation of the Ulthera\u00ae System for Lifting and Tightening of Facial and Neck Skin Laxity Using a Customized, High-Density and Vectoring Treatment Approach", 
        "overall_official": {
            "last_name": "William P Werschler, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "As determined by a masked, qualitative assessment of photographs at 90 days post treatment compared to baseline. The clinical response of Ulthera treatment will be assessed by comparing photographic images taken before and after the procedure.", 
            "measure": "Improvement in overall lifting and tightening of the skin", 
            "safety_issue": "No", 
            "time_frame": "90 days post-treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01708512"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Global Aesthetic Improvement Scale scores will be obtained from the Investigator and subject, assessing improvement in skin laxity based on a comparison of post-treatment photos to pre-treatment photos.", 
            "measure": "Overall aesthetic improvement", 
            "safety_issue": "No", 
            "time_frame": "365 days post-treatment"
        }, 
        "source": "Ulthera, Inc", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ulthera, Inc", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}